English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Amanda Rupp | May 23, 2016

AstraZeneca emphasizes oncology pipeline progress

+ Community
Amanda Rupp | May 23, 2016

Health experts commit to ending U.S. opioid addiction epidemic

+ Technology/Innovation
Amanda Rupp | May 23, 2016

Opdivo trials show sustained improvements for patients with advanced NSCLC

+ Regulatory
Kim Sunderland | May 23, 2016

American College of Emergency Physicians survey examines problems with ‘affordable’ insurance

+ Community
Amanda Rupp | May 23, 2016

Final rules from FDA to help consumers identify crucial nutritional information

+ Technology/Innovation
Amanda Rupp | May 22, 2016

New ALS research announced at annual conference

+ Technology/Innovation
Amanda Rupp | May 22, 2016

AstraZeneca releases positive outcomes from severe asthma study

+ Community
Amanda Rupp | May 22, 2016

Patients encouraged to know, improve high blood pressure numbers

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 453
  • 454
  • 455
  • 456
  • 457
  • 458
  • 459
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily